Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Santos shares slump as Adnoc pulls $19bn takeover

(Sharecast News) - Shares in Australian natural gas group Santos plunged on Thursday after Abu Dhabi's state oil company walked away from its $18.7bn offer. Adnoc and private equity outfit Carlyle joined forces to table what would have been Australia's largest takeover but pulled their offer late on Wednesday citing a "combination of factors".

The proposed deal required a range of regulatory approvals along with the Foreign Investment Review Board, which provides advice to the country's Treasurer Jim Chalmers.

However, despite support from the company's board, it had come under fire from Australian trades unions.

Santos shares fell 12% on the Australian Stock Exchange.

"The XRG consortium would not agree to acceptable terms which protected the value of the potential transaction for Santos shareholders, having regard to the likely extended timeframe to completion and the regulatory risk associated with the transaction," Santos said in a statement.

Santos had previously failed to seal takeover deals with US company Harbour Energy in 2018 and last year with domestic rival Woodside Energy.

Company chairman Keith Spence moved to allay investor concerns, saying the miner "has a clear strategy, strong leadership and high-quality growth opportunities across our global portfolio".

"The board is confident these strengths will deliver long-term value for shareholders."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.